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Background: An adequate renal biopsy is essential for diagnosis and treatment of medical renal disease.
Objective: We evaluated two initiatives to improve adequacy of renal biopsy samples at our centre.
Design: Retrospective determination of renal biopsy adequacy.
Setting: Queen Elizabeth II Health Sciences Centre.
Patients: Patients undergoing medical renal biopsies.
Measurements: Renal biopsy adequacy.
Methods: The first initiative was to restrict the performance of biopsies to a smaller group of radiologists and to
include a comment on biopsy adequacy in every pathology report. The second initiative was to introduce on-site
adequacy assessment by a medical laboratory technologist. Native renal and allograft biopsy adequacies were
calculated for three periods: 1) baseline, October 2005 to September 2006; 2) after implementation of the first
initiative, January 2007 to September 2011; and 3) after implementation of the second initiative, October 2011 to
September 2012. A subset of native renal biopsies was examined to determine if there was a relationship between
adequacy and number of passes.
Results: The percentages of adequate native renal biopsies during the first, second, and third periods were 31%,
72% and 90%, respectively. This represents a significant increase (40%, p < 0.0001) in adequacy following the first
initiative, and another significant increase (18%, p = 0.0003) following the second initiative. The percentages of
adequate renal allograft biopsies during the first, second, and third periods were 75%, 56% and 69%, respectively.
These changes in adequacy were not statistically significant. In the subset of native renal biopsies examined, a
biopsy comprising more than three cores was not associated with increase in adequacy.
Limitations: The most important limitation is the lack of generally accepted and applied adequacy criteria limiting
generalizability of our findings.
Conclusions: Restricting the performance of biopsies to subspecialist operators, including an adequacy statement
in the renal biopsy report and on-site adequacy assessment were effective in significantly improving native renal
biopsy adequacy. This improvement appeared unrelated to an increase in the number of passes taken with a
biopsy needle. Neither initiative improved the low adequacy of allograft biopsies.
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Contexte: L’importance que joue la biopsie percutanée dans le diagnostic et le traitement des maladies rénales est
un fait bien connu. Un spécimen adéquat est nécessaire pour une interprétation correcte des résultats. La
surveillance de la qualité de biopsie reste une pratique importante de contrôle de la qualité.
Objectif de l’étude: Deux initiatives visant une meilleure qualité des échantillons rénaux pour la biopsie ont été
évaluées à notre centre.
Type d’étude: Détermination rétrospective de la qualité de la biopsie rénale.
Contexte: Le Queen Elizabeth II Health Sciences Centre.
Patients: Patients subissant des biopsies rénales.
Mesures: Qualité de la biopsie rénale.
Méthodes: La première initiative visait à restreindre la réalisation des biopsies à un petit groupe de radiologues et
d’ajouter un commentaire sur la qualité de la biopsie dans chaque rapport de pathologie. La deuxième initiative
visait à implanter l’évaluation de cette qualité sur place, par l’intermédiaire d’un technicien de laboratoire médical.
La qualité des biopsies de reins natifs et d’allogreffes ont été calculées en trois temps : 1) mesure de référence:
d’octobre 2005 à septembre 2006; 2) après l’implantation de la première initiative, de janvier 2007 à septembre
2011; 3) après l’implémentation de la deuxième initiative, d’octobre 2011 à septembre 2012. Un sous-ensemble de
biopsies effectuées sur des reins natifs a été examiné afin de déterminer s’il existait un lien entre la qualité et le
nombre de ponctions.
Résultats: Les pourcentages d’une qualité adéquate des biopsies de reins natifs des trois phases étaient de 31%,
72% et 90%, respectivement. On remarque des hausses de la qualité des biopsies importantes après la première
initiative (40%, p < 0,0001) et après la deuxième (18%, p = 0,0003). Les pourcentages d’une qualité adéquate des
biopsies d’allogreffes rénales des trois étapes étaient de 75%, 56% et 69%, respectivement; ces changements
n’étaient pas statistiquement significatifs. Dans le sous-ensemble des biopsies de reins natifs, celles de plus de trois
échantillons n’étaient pas associées avec une hausse de la qualité.
Limites de l’étude: Parmi les limites de l’étude, on compte les données lacunaires concernant : les complications
postopératoires; l’analyse détaillée des caractéristiques des radiologistes avant et après la première intervention;
certaines données permettant de mesurer l’effet de la deuxième intervention indépendamment de son lien avec la
première intervention; un consensus sur les critères de la qualité des biopsies de reins natifs et d’allogreffes rénales
à des fins de comparaisons entre les différentes institutions, et qui s’est répercuté sur la généralisabilité de nos
résultats (provenant d’un seul centre) à d’autres établissements. Le manque de puissance statistique a limité la
possibilité de détecter certaines différences entre les sous-groupes.
Conclusions: La restriction de la réalisation des biopsies par une sous-spécialité, l’ajout d’un commentaire sur la
qualité de la biopsie rénale dans le rapport, et l’évaluation sur place de la qualité ont eu l’effet d’améliorer de façon
significative la proportion de biopsies rénales natives avec une qualité adéquate. Cette amélioration ne semble pas
liée à une hausse du nombre de ponctions faites avec une aiguille à biopsie. Aucune des initiatives n’a amélioré la
basse qualité des biopsies d’allogreffes.What was known before
An adequate renal biopsy specimen is required for ac-
curate interpretation.
What this adds
Restricting the performance of biopsies to subspecialist
operators, including an adequacy statement in the renal
biopsy report and on-site adequacy assessment were ef-
fective in significantly improving native renal biopsy ad-
equacy. The increase in adequacy was not related to an
increase in number of passes with a biopsy needle to a
statistically significant extent.Background
The importance of the percutaneous biopsy in the
diagnosis and treatment of renal diseases is well-
established [1]. The renal biopsy procedure that yields
clinically relevant information is a multidisciplinary
task that depends upon close cooperation between
nephrologists, radiologists, technologists and patholo-
gists [2]. An adequate specimen is required for accurate
interpretation [3]. Inadequate specimens result in delays
in diagnosis and treatment, and increased health-care
costs in addition to the risk of a repeated biopsy proced-
ure. Because of the impact on patient care, monitoring
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Historically, the definition of an adequate biopsy has
been based upon either: 1) the opinion of the pathologist
that there is sufficient tissue to make a diagnosis, or 2)
fixed criteria based upon the number of glomeruli and
vessels present in the specimen. In the case of allograft
biopsies, the numerical criteria established in the Banff
97 guidelines have been generally accepted and applied
[4,5]. Despite the statistical demonstration of minimum
glomerular counts needed to exclude and accurately stage
focal renal disease [3,6], no numerical adequacy criteria
for native renal biopsies have found wide acceptance.
At our centre locally defined numerical criteria were
applied as part of a clinical audit of renal biopsy ad-
equacy. It was retrospectively determined that the per-
centage of adequate native renal biopsies for the period
between October, 2005, and September, 2006, was 31%,
which was much lower than adequacy reported in the
literature. Specific reasons for this unusually low adequacy
could not be identified, and even allowing for the difficul-
ties of comparison caused by the lack of established ad-
equacy criteria in the literature, the local adequacy was
felt to be sufficiently low to require intervention. Over the
course of six years, two separate initiatives to improve ad-
equacy were implemented through the cooperation of
members of the Departments of Pathology, Medicine and
Diagnostic Radiology. This paper investigates whether
these interventions, including restricting the performance
of biopsies to subspecialist operators, provision of an ad-
equacy statement in all renal biopsy reports and on-site




Ethical approval derives from the a priori approval
granted by the Research Ethics Board of the Capital District
Health Authority to the Division of Anatomical Pathology
to use aggregate de-identified patient data for quality
improvement purposes.
Setting
The Queen Elizabeth II Health Sciences Centre is a
university-affiliated referral centre with an active renal
transplant program that performs an average of 90
transplants per year. The anatomical pathology laboratory
processes and reports approximately 200 native renal bi-
opsies and 100 renal allograft biopsies per year, a number
that has remained fairly stable over the last few years.
Participants
An analysis of adequacy for percutaneous renal biopsies
performed at our centre was conducted using aggregatede-identified patient data. Biopsies performed at other
centers and intraoperative biopsies were excluded from
the analysis.
Interventions
The first intervention included:
1. Restriction of the performance of biopsies to a
group of 11 radiologists from a group of
approximately 20 radiologists with a subspecialty
interest in this field of practice. No attempt was
made to standardize biopsy technique among
operators. All biopsies were performed with 16
gauge biopsy guns (C. R. Bard Inc., Murray Hill,
New Jersey, USA) under real-time ultrasound
guidance.
2. Provision of assessment of biopsy adequacy in every
renal pathology report. Adequacy criteria for renal
biopsies were locally defined through review of the
literature, and discussion and consensus between the
two renal pathologists who were practicing at the
time that this was introduced. Two additional renal
pathologists who participated in signing out renal
biopsy reports during the course of the study also
included the comment in their reports. It continues
to be a standard statement in each renal biopsy
report in our centre.
The second intervention was to have a medical labora-
tory technologist perform adequacy assessment on-site
in the biopsy suite. The sample was examined under a
dissecting microscope and the presence of glomeruli de-
termined. If the sample was judged not to have glomeruli
in any one of the cores for light, immunofluorescence or
electron microscopy, then an additional core could be ob-
tained. Three medical laboratory technologists were
trained by pathologists assistants to identify glomeruli in
renal biopsies examined under a dissecting microscope.
The pathologists assistants had been trained previously by
a renal pathologist. Any suboptimal or inadequate biopsies
were discussed with the medical laboratory technologists
after the renal biopsy report had been verified in an at-
tempt to ascertain the reason why the particular renal bi-




1. Adequate biopsies contained at least ten glomeruli
for light microscopy and at least one glomerulus
each for immunofluorescence and electron
microscopy.
Geldenhuys et al. Canadian Journal of Kidney Health and Disease  (2015) 2:8 Page 4 of 72. Biopsies that did not meet these criteria but
contained at least one glomerulus each for light,
immunofluorescence and electron microscopy were
classified as sub-optimal.
3. Biopsies that failed to meet the sub-optimal criteria
were classified as inadequate.
Renal allograft biopsies
1. Adequate specimens contained ten or more
glomeruli, two or more arteries, and at least one
glomerulus each for immunofluorescence and
electron microscopy.
2. Suboptimal specimens contained at least one
glomerulus each for light, immunofluorescence and
electron microscopy, and at least one artery, but did
not meet the full adequacy criteria.
3. Allograft specimens that failed to meet the sub-optimal
criteria were classified as inadequate.
Data analysis
The percentages of adequate, suboptimal and inadequate
native renal and allograft biopsies were calculated for
three periods:
Period 1: Baseline, October 2005 to September 2006
(12 months). Adequacy was determined retrospectively
by a renal pathologist reviewing the renal biopsy report
and applying the numerical adequacy criteria.
Period 2: After implementation of the first initiative,
January 2007 to September 2011 (57 months). For renal
biopsies from this period an adequacy statement was
included in the renal biopsy report by the renal
pathologist by applying the numerical adequacy criteria.
Renal biopsy adequacy was monitored by auditing the
adequacy statement in renal biopsy reports every three
months.
Period 3: After implementation of the second initiative,
October 2011 to September 2012 (12 months).
Adequacy was determined as for period 2 above.
The differences in adequacy between periods were
expressed as the change in percentage of adequacy in
the period in question compared to the preceding
period, i.e. period 2 compared to period 1, and period 3
compared to period 2, with 95% exact confidence inter-
vals. The Fisher’s exact test was applied to determine the
statistical significance of the changes between periods. A
two-tailed probability was used with an alpha level of
0.05 used to determine significance.
After analyzing our results, in order to evaluate the re-
lationship between the interventions and the improve-
ment in adequacy, we questioned whether potential
improvement was contributed to by an increase in thenumber of passes taken with the biopsy gun during renal
biopsy collection. Since the number of tissue cores sub-
mitted would approximate the number of passes, we ex-
amined a subset of the native renal biopsies comparing
the number of cores recorded in the renal biopsy report
with adequacy for three consecutive three month periods:
Subset period 1: Prior to implementing the
interventions, July, August and September, 2006
Subset period 2: Between implementing the first and
second sets of interventions, July, August and
September, 2011
Subset period 3: After implementing the second set of
interventions, July, August and September, 2012
The Fisher’s exact test was applied to determine the
statistical significance of the difference in proportions of
biopsies with greater than three cores between adequate
and suboptimal or inadequate biopsies in each subset
period.
Statistical calculations were performed using SAS version
9.4 (Cary, North Carolina, USA).
Results
A total of 663 native renal biopsies and 339 allograft
renal biopsies were included in our study.
During periods 2 and 3 the number of radiologists
decreased from approximately 20 during the first
period, to 11.
All reports during periods 2 and 3 contained an ad-
equacy statement.
All renal biopsies during period 3 were assessed on
site for the presence of glomeruli by one of three med-
ical laboratory technologists.
The percentages of adequate, suboptimal and inad-
equate native renal biopsies during all three periods are
listed in Table 1. The percentages of adequate biopsies
for periods 1, 2 and 3 were 31%, 72% and 90%, respect-
ively. This represents a significant increase (40%, 95%
CI: 31% – 50%, p < 0.0001) in adequacy following the
first initiative, and another significant increase (18%,
95% CI: 8% – 29%, p = <0.0001) following the second
initiative.
The percentages of adequate, suboptimal and inad-
equate allograft renal biopsies are listed in Table 2. The
percentages of adequate biopsies for periods 1, 2 and 3
were 75%, 56% and 69%, respectively. This represents a
decrease in adequacy that is not statistically significant
(19%, 95% CI: 4% – 41%, p = 0.16) following the first ini-
tiative, and an increase that is not statistically significant
(13%, 95% CI: 2% – 28%, p = 0.11) following the second
initiative.
The subset of native renal biopsies analyzed for ad-
equacy and number of cores comprised a total of 79
Table 1 Summary of adequacy assessment of native renal biopsies









1 127 40 (31%) 43 (34%) 44 (35%) NA NA
2 432 311 (72%) 54 (13%) 67 (16%) +40% (31, 50) < 0.0001
3 104 94 (90%) 2 (2%) 8 (8%) +18% (8, 29) <0.0001
*Change of percentage of adequacy in the period in question compared to the preceding period, i.e. comparing period 2 to period 1, and comparing period 3 to
period 2.
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period; and number and percentage of adequate biopsies
comprising more than three cores, compared to subopti-
mal and inadequate biopsies comprising more than three
cores are listed in Table 3. Percentages of adequate biop-
sies for subset periods 1, 2 and 3 were 37%, 81% and
95% respectively showing the same gradual increase in
adequacy after each of the interventions as in the larger
data set. Adequate biopsies were less likely than subopti-
mal or inadequate biopsies to comprise more than three
cores during subset period 1, while the opposite was true
in subset periods 2 and 3, suggesting that one factor in
adequacy may be an increase in core number, but these
trends were not statistically significant.
Discussion
Our results show that restricting the performance of bi-
opsies to subspecialist operators, including an adequacy
statement in the renal biopsy report and on-site ad-
equacy assessments were effective in significantly im-
proving native renal biopsy adequacy. The combined
effect of these two initiatives brought our centre’s renal
biopsy adequacy to within the range reported in the lit-
erature [7-10]. Neither initiative was seen to result in a
significant difference in allograft biopsy adequacy.
Analysis of a subset of native renal biopsies showed a
trend of a greater number of biopsies comprising more
than three cores in the adequate group as opposed to
the suboptimal and inadequate group after each set of
interventions, but the trend was not statistically signifi-
cant. Factors such as awareness by radiologists of the
issue, reducing the number of radiologists performing
the procedure, therefore increasing their experience,
feedback on performance to the operator though the ad-
equacy statement in the report, enhanced by the physical
presence of the medical laboratory technologist duringTable 2 Summary of adequacy assessment of renal allograft b




1 20 15 (75%) 0 (0%)
2 270 152 (56%) 81 (30%
3 49 34 (69%) 9 (18%)
*Change of percentage of adequacy in the period in question compared to the pre
period 2.the procedure may also play a role in improving renal
biopsy adequacy.
One limitation of our study is that it did not assess the
impact of the initiatives upon the incidence of post-
procedure complications. Intuitively, one might expect
that on-site adequacy assessment would increase the
number of cores obtained at biopsy, and this in turn
would result in an increase in complications. Manno
et al. [11] observed no significant difference in complica-
tions in cases where a single tissue core was obtained
compared to cases where multiple tissue cores were ob-
tained in a prospective series of 417 biopsies. Patel et al.
[12] point out that no previously reported series has dem-
onstrated an increase in complications associated with
obtaining more than one tissue core at biopsy.
The full adequacy criteria in our study for both native
renal and allograft biopsies are more stringent than
those found in most studies [2,4,5,7-17]. This is espe-
cially true in the case of native renal biopsies where ad-
equacy has traditionally meant sufficient material to
render a diagnosis. Partly as a consequence of this more
inclusive standard, published adequacy percentages are
high, between 89 and 100% [7-10]. However, there is
support in the literature for the application of numerical
criteria to native renal biopsies. The need for a mini-
mum number of glomeruli to identify focal disease and
to accurately classify disease activity has been demon-
strated statistically [3,6]. Electron microscopy and im-
munofluorescence are often necessary to make a correct
diagnosis, and the cases in which they are not necessary
cannot be reliably predicted [2]. Consequently, we be-
lieve that our criteria are appropriate for assessing the
diagnostic value of native renal biopsy specimens.
For allograft biopsies our adequacy percentages are
within the range of those reported in the literature








5 (25%) NA NA
) 37 (14%) −19% (4, 41) = 0.16
6 (12%) +13% (2, 28) = 0.11
ceding period, i.e. comparing period 2 to period 1, and comparing period 3 to
Table 3 Summary of adequacy assessment of subset of native renal biopsies, comparing number and percentage of
adequate biopsies comprising more than three cores, to suboptimal and inadequate biopsies comprising more than
three cores
Period Total biopsies (n) Adequacy in subset (%) Number (%) adequate biopsies
comprising cores >3
Number (%) suboptimal and inadequate
biopsies comprising cores >3
p- value*
1 27 37% 3 (30.0%) 10 (58.8%) 0.10
2 31 80% 10 (40.0%) 2 (33.3%) 1
3 21 95% 7 (26.9%) 1 (16.6%) 1
*Comparing number and percentage adequate of biopsies comprising more than three cores, to suboptimal and inadequate biopsies comprising more than
three cores.
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ation in the application of the Banff 97/07 adequacy cri-
teria. Of note, the study with the highest reported
adequacy used adequacy criteria of seven glomeruli and
at least one artery, stating that the Banff 97 criteria
stipulate that both adequate and suboptimal specimens
indicate procedural success [12]. While this is true, we
believe that stratification into fully adequate and sub-
optimal categories meaningfully reflects the diagnostic
value of the specimen. Apart from these issues, the fact
that both initiatives failed to significantly improve allo-
graft biopsy adequacy is disappointing. We plan to inves-
tigate potential contributing factors as part of the
ongoing quality improvement process for this important
outcome.
Limitations
Limitations include lack of the following:
1. Data on post-procedure complications, discussed
above
2. Detailed analysis of the characteristics of the
radiologists before and after the first intervention
3. Generally accepted and applied adequacy criteria for
native and allograft renal biopsies in the literature to
compare data between institutions impacting the
generalizability our findings from a single centre to
other institutions
4. Data to measure the impact of the second
intervention independent of the ongoing impact of
the first
5. Power to detect several sub-group differences
Conclusion
Restricting the performance of biopsies to subspecialist
operators, provision of a renal biopsy adequacy state-
ment and on-site adequacy assessment are effective in
significantly improving native renal biopsy adequacy.
None of these changes results in a significant improve-
ment in allograft biopsy adequacy. Therefore, increasing
awareness of radiologists regarding adequacy, developing
a pool of expert radiologists performing the procedure,
providing feedback on performance to the operatorthrough an adequacy statement in the report, and phys-
ical presence of the medical laboratory technologist dur-
ing the procedure may improve native renal biopsy
adequacy.
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